Merck Manual

Please confirm that you are a health care professional

honeypot link

Overview of Congenital Adrenal Hyperplasia

(Adrenogenital Syndrome; Adrenal Virilism)


Andrew Calabria

, MD, The Children's Hospital of Philadelphia

Reviewed/Revised Aug 2022 | Modified Sep 2022
View Patient Education

Congenital adrenal hyperplasia is a group of genetic disorders, each characterized by inadequate synthesis of cortisol, aldosterone, or both. In the most common forms, accumulated hormone precursors are shunted into androgen production, causing androgen excess; in rarer forms, synthesis of androgens is also inadequate.

In the various forms of congenital adrenal hyperplasia, production of cortisol (a glucocorticoid), aldosterone (a mineralocorticoid), or both is impaired because of an autosomal recessive genetic defect in one of the adrenal enzymes involved in synthesizing adrenal steroid hormones from cholesterol. The enzyme may be absent or deficient, completely or partially disabling synthesis of cortisol, aldosterone, or both. In the forms in which cortisol synthesis is absent or decreased, adrenocorticotropic hormone (ACTH, corticotropin) release, normally suppressed by cortisol, is excessive.

In some less common forms affecting enzymes other than 21-hydroxylase and 11beta-hydroxylase, the enzyme block impairs androgen synthesis (dehydroepiandrosterone [DHEA] or androstenedione). As a result, virilization of males is inadequate, but no defect is discernible in females.

Drugs Mentioned In This Article

Drug Name Select Trade
Acthar, CORTROPHIN, H.P. Acthar
View Patient Education
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz!